Correlation between HER2 Overexpression and Clinicopathological Characteristics in Gastric Cancer Patients Who Have Undergone Curative Resection

PURPOSE: At present, a human epidermal growth factor receptor 2 (HER2)-based concept of tumor biology has been established, and trastuzumab (Herceptin®; Genentech/Roche, San Francisco, CA, USA), a monoclonal humanized antibody directed against HER2, is a pivotal agent for the management of HER2 posi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Son, Ho Sung, Shin, Yeon Myung, Park, Kwang Kuk, Seo, Kyung Won, Yoon, Ki Young, Jang, Hee Kyung, Lee, Sang-Ho, Yang, Song I, Kim, Jeong Hoon
Format: Artigo
Idioma:Inglês
Publicat: The Korean Gastric Cancer Association 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4199885/
https://ncbi.nlm.nih.gov/pubmed/25328763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5230/jgc.2014.14.3.180
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars